Envoy Medical and TearLab: Comparing Medical Device Companies

An analysis of the two firms' financial performance, ratings, and ownership

Feb. 24, 2026 at 9:52am

Got story updates? Submit your updates here. ›

TearLab (OTCMKTS:TEAR) and Envoy Medical (NASDAQ:COCH) are both medical device companies, but which one is the better investment? This article compares the two firms based on factors like net margins, return on equity, analyst ratings, institutional ownership, revenue, and earnings per share.

Why it matters

Investors looking to gain exposure to the medical device industry may be interested in comparing these two companies to determine which one is the stronger investment option based on their financial performance and other key metrics.

The details

The analysis finds that Envoy Medical outperforms TearLab on 6 out of 8 factors compared, including having higher institutional ownership, insider ownership, and revenue. TearLab does have higher earnings per share than Envoy Medical. Overall, the data suggests Envoy Medical may be the superior investment between the two medical device firms.

  • The article was published on February 24, 2026.

The players

TearLab Corporation

An in-vitro diagnostic company that offers the TearLab Osmolority System, a tear film testing platform for diagnosing dry eye disease. The company is headquartered in San Diego, California.

Envoy Medical, Inc.

A hearing health company that provides medical technologies for hearing loss, including personal sound amplification devices, hearing aids, and implantable hearing solutions. Envoy Medical is headquartered in White Bear Lake, Minnesota.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the key differences between these two medical device firms, providing investors with data-driven insights to help them determine which company may be the better investment option based on factors like financial performance, analyst ratings, and ownership structure.